Ps. Heckerling et al., PRENATAL TESTING FOR LIMB REDUCTION DEFECTS - HOW PATIENTS VIEWS AFFECT THEIR CHOICE OF CVS, Journal of reproductive medicine, 42(2), 1997, pp. 114-120
OBJECTIVE: To determine the effect of reports and media coverage on ch
orionic villus sampling (CVS) and limb reduction defects (LRD) on pati
ents' utilization of CVS for prenatal testing for advanced maternal ag
e and to quantitate the relation of preferences for CVS and amniocente
sis (AMN) outcomes to test utilization. STUDY DESIGN: We compared CVS
and AMN utilization rates in two groups of women seen at one academic
medical center before and after publicity concerning CVS and LRD. We m
easured preferences, in rating-scale units, for potential outcomes of
prenatal testing in the after-publicity group. Relationships between p
references and CVS utilization were examined using multivariate method
s. RESULTS: The proportion of women utilizing CVS for prenatal testing
declined significantly for the after-publicity group (23%) as compare
d with the prepublicity group (47.4%, P = .0001). Belief that the birt
h of It child with LRD after CVS was worse than a similar birth after
AMN significantly reduced the odds of choosing CVS. A decrement in pre
ference for a child with LRD after CVS of 5 rating-scale units reduced
the likelihood of CVS by 15% (confidence interval [CI], 1-28%); a dec
rement of 10 units reduced the likelihood of CVS by 28% (CI, 1-48%). T
his effect persisted after adjustment for demographic and obstetric co
variates, prior prenatal testing, locus of decision making (patient ve
rsus physician or shared) and other maternal preferences for outcomes
of prenatal testing. CONCLUSION: Lower patient preference for a child
with LRD after CVS was an independent predictor of choosing AMN over C
VS and was probably responsible for the significant de crease in CVS u
tilization at our hospital.